• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原花青素三聚体 C1 与甘遂和 JQ1 联合作为三重组合疗法激活潜伏 HIV。

Procyanidin trimer C1 reactivates latent HIV as a triple combination therapy with kansui and JQ1.

机构信息

Departments of Medicine, Microbiology and Immunology, University of California at San Francisco, San Francisco, California, United States of America.

出版信息

PLoS One. 2018 Nov 26;13(11):e0208055. doi: 10.1371/journal.pone.0208055. eCollection 2018.

DOI:10.1371/journal.pone.0208055
PMID:30475902
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6258234/
Abstract

Although anti-retroviral therapies have greatly extended the lives of HIV infected individuals, current treatments are unable to completely eliminate virally infected cells. A number of latency reversing agents have been proposed for use in a "shock and kill" strategy to reactivate latent HIV, thus making it vulnerable to killing mechanisms. Procyanidin trimer C1 (PC1) is a flavonoid found in multiple plant sources including grape, apple, and cacao, which has antioxidant and anti-inflammatory properties. We determined that PC1 reactivates latent HIV in cell line and primary cell models of HIV, through activation of the MAPK pathway. Notably, PC1 reactivates latent HIV without increasing surface markers of T cell activation. Combining several therapeutics, which activate HIV transcription through different mechanisms, is the most efficient approach to clinically reactivate latent reservoirs. We utilized PC1 (MAPK agonist), kansui (PKC agonist), and JQ1 (BET bromodomain inhibitor) in a triple combination approach to reactivate latent HIV in cell line and primary cell models of HIV latency. When used in combination, low concentrations which fail to reactivate HIV as single treatments, are effective. Thus, several mechanisms, using distinct activation pathways, act together to reactivate latent HIV.

摘要

虽然抗逆转录病毒疗法大大延长了 HIV 感染者的生命,但目前的治疗方法无法完全清除病毒感染的细胞。已经提出了许多潜伏逆转剂,用于“震撼和杀伤”策略,以重新激活潜伏的 HIV,从而使其容易受到杀伤机制的影响。原花青素三聚体 C1(PC1)是一种在多种植物来源中发现的类黄酮,包括葡萄、苹果和可可,具有抗氧化和抗炎特性。我们确定 PC1 通过激活 MAPK 途径重新激活细胞系和 HIV 原代细胞模型中的潜伏 HIV。值得注意的是,PC1 重新激活潜伏 HIV 而不会增加 T 细胞激活的表面标志物。通过不同机制激活 HIV 转录的几种治疗方法是临床重新激活潜伏储库的最有效方法。我们在细胞系和 HIV 潜伏原代细胞模型中使用 PC1(MAPK 激动剂)、甘遂(PKC 激动剂)和 JQ1(BET 溴结构域抑制剂)的三联组合方法重新激活潜伏 HIV。当联合使用时,即使作为单一治疗方法也无法重新激活 HIV 的低浓度也有效。因此,几种使用不同激活途径的机制共同作用以重新激活潜伏的 HIV。

相似文献

1
Procyanidin trimer C1 reactivates latent HIV as a triple combination therapy with kansui and JQ1.原花青素三聚体 C1 与甘遂和 JQ1 联合作为三重组合疗法激活潜伏 HIV。
PLoS One. 2018 Nov 26;13(11):e0208055. doi: 10.1371/journal.pone.0208055. eCollection 2018.
2
The Novel PKC Activator 10-Methyl-Aplog-1 Combined with JQ1 Induced Strong and Synergistic HIV Reactivation with Tolerable Global T Cell Activation.新型 PKC 激活剂 10-甲基-aplog-1 与 JQ1 联合诱导强烈且协同的 HIV 激活,同时具有可耐受的整体 T 细胞激活。
Viruses. 2021 Oct 9;13(10):2037. doi: 10.3390/v13102037.
3
Euphorbia Kansui Reactivates Latent HIV.甘遂可重新激活潜伏的艾滋病毒。
PLoS One. 2016 Dec 15;11(12):e0168027. doi: 10.1371/journal.pone.0168027. eCollection 2016.
4
Procyanidin trimer C1 derived from Theobroma cacao reactivates latent human immunodeficiency virus type 1 provirus.源自可可树的原花青素三聚体C1可重新激活潜伏的1型人类免疫缺陷病毒前病毒。
Biochem Biophys Res Commun. 2015 Apr 3;459(2):288-293. doi: 10.1016/j.bbrc.2015.02.102. Epub 2015 Feb 26.
5
A New Quinoline BRD4 Inhibitor Targets a Distinct Latent HIV-1 Reservoir for Reactivation from Other "Shock" Drugs.一种新型喹啉类 BRD4 抑制剂,针对潜伏 HIV-1 储库的另一个不同靶点,可被其他“休克”药物激活。
J Virol. 2018 Apr 27;92(10). doi: 10.1128/JVI.02056-17. Print 2018 May 15.
6
A novel bromodomain inhibitor, CPI-203, serves as an HIV-1 latency-reversing agent by activating positive transcription elongation factor b.一种新型溴结构域抑制剂 CPI-203 通过激活正转录延伸因子 b 来作为 HIV-1 潜伏期逆转剂。
Biochem Pharmacol. 2019 Jun;164:237-251. doi: 10.1016/j.bcp.2019.04.005. Epub 2019 Apr 13.
7
Ex vivo analysis identifies effective HIV-1 latency-reversing drug combinations.体外分析确定了有效的HIV-1潜伏逆转药物组合。
J Clin Invest. 2015 May;125(5):1901-12. doi: 10.1172/JCI80142. Epub 2015 Mar 30.
8
4-Deoxyphorbol inhibits HIV-1 infection in synergism with antiretroviral drugs and reactivates viral reservoirs through PKC/MEK activation synergizing with vorinostat.4-去氧胆酸抑制 HIV-1 感染与抗逆转录病毒药物协同作用,并通过与伏立诺他协同激活 PKC/MEK 来重新激活病毒储存库。
Biochem Pharmacol. 2020 Jul;177:113937. doi: 10.1016/j.bcp.2020.113937. Epub 2020 Mar 26.
9
BET bromodomain inhibition as a novel strategy for reactivation of HIV-1.BET 溴结构域抑制作为一种新型的 HIV-1 重新激活策略。
J Leukoc Biol. 2012 Dec;92(6):1147-54. doi: 10.1189/jlb.0312165. Epub 2012 Jul 16.
10
Thiostrepton Reactivates Latent HIV-1 through the p-TEFb and NF-κB Pathways Mediated by Heat Shock Response.热休克反应通过 p-TEFb 和 NF-κB 通路介导硫链丝菌素重新激活潜伏的 HIV-1。
Antimicrob Agents Chemother. 2020 Apr 21;64(5). doi: 10.1128/AAC.02328-19.

引用本文的文献

1
Latency Reversing Agents and the Road to an HIV Cure.潜伏期逆转剂与治愈艾滋病的道路。
Pathogens. 2025 Feb 27;14(3):232. doi: 10.3390/pathogens14030232.
2
Ethnobotanical survey and phytochemistry of medicinal plants used in the management of HIV/AIDS in Eastern Uganda.乌干达东部用于治疗艾滋病毒/艾滋病的药用植物的民族植物学调查与植物化学研究
Heliyon. 2024 May 24;10(11):e31908. doi: 10.1016/j.heliyon.2024.e31908. eCollection 2024 Jun 15.
3
Broad-spectrum antiviral activity of Spatholobus suberectus Dunn against SARS-CoV-2, SARS-CoV-1, H5N1, and other enveloped viruses.

本文引用的文献

1
Characterization of designed, synthetically accessible bryostatin analog HIV latency reversing agents.设计的、可合成获得的苔藓抑素类似物 HIV 潜伏逆转剂的表征。
Virology. 2018 Jul;520:83-93. doi: 10.1016/j.virol.2018.05.006. Epub 2018 May 26.
2
Natural Products and HIV/AIDS.天然产物与艾滋病毒/艾滋病
AIDS Res Hum Retroviruses. 2018 Jan;34(1):31-38. doi: 10.1089/AID.2017.0232. Epub 2018 Jan 10.
3
Euphorbia Kansui Reactivates Latent HIV.甘遂可重新激活潜伏的艾滋病毒。
鸡血藤对 SARS-CoV-2、SARS-CoV-1、H5N1 及其他包膜病毒具有广谱抗病毒活性。
Phytother Res. 2022 Aug;36(8):3232-3247. doi: 10.1002/ptr.7452.
4
Knowledge From London and Berlin: Finding Threads to a Functional HIV Cure.伦敦与柏林的经验:探寻功能性 HIV 治愈方法。
Front Immunol. 2021 May 27;12:688747. doi: 10.3389/fimmu.2021.688747. eCollection 2021.
5
HIV-1 Latency and Viral Reservoirs: Existing Reversal Approaches and Potential Technologies, Targets, and Pathways Involved in HIV Latency Studies.HIV-1 潜伏期和病毒储存库:现有逆转方法以及 HIV 潜伏期研究中涉及的潜在技术、靶点和途径。
Cells. 2021 Feb 23;10(2):475. doi: 10.3390/cells10020475.
6
Experimental Systems for Measuring HIV Latency and Reactivation.用于测量 HIV 潜伏期和激活的实验系统。
Viruses. 2020 Nov 9;12(11):1279. doi: 10.3390/v12111279.
7
Current Status of Latency Reversing Agents Facing the Heterogeneity of HIV-1 Cellular and Tissue Reservoirs.面对HIV-1细胞和组织储存库异质性的潜伏期逆转剂的现状
Front Microbiol. 2020 Jan 24;10:3060. doi: 10.3389/fmicb.2019.03060. eCollection 2019.
PLoS One. 2016 Dec 15;11(12):e0168027. doi: 10.1371/journal.pone.0168027. eCollection 2016.
4
Patient-Reported Barriers to Adherence to Antiretroviral Therapy: A Systematic Review and Meta-Analysis.患者报告的抗逆转录病毒治疗依从性障碍:系统评价与荟萃分析
PLoS Med. 2016 Nov 29;13(11):e1002183. doi: 10.1371/journal.pmed.1002183. eCollection 2016 Nov.
5
Targeting the latent reservoir to achieve functional HIV cure.针对潜伏病毒库以实现功能性治愈艾滋病病毒。
F1000Res. 2016 May 26;5. doi: 10.12688/f1000research.8109.1. eCollection 2016.
6
Molecular mechanisms of HIV latency.HIV潜伏的分子机制。
J Clin Invest. 2016 Feb;126(2):448-54. doi: 10.1172/JCI80565. Epub 2016 Jan 5.
7
Characterization of Non-Anthocyanic Flavonoids in Some Hybrid Red Grape Extracts Potentially Interesting for Industrial Uses.某些具有潜在工业用途的杂交红葡萄提取物中非花青素类黄酮的特性分析。
Molecules. 2015 Oct 2;20(10):18095-106. doi: 10.3390/molecules201018095.
8
Synergistic Reactivation of Latent HIV Expression by Ingenol-3-Angelate, PEP005, Targeted NF-kB Signaling in Combination with JQ1 Induced p-TEFb Activation.ingenol-3-当归酸酯(PEP005)通过靶向NF-κB信号通路协同重新激活潜伏性HIV表达,并与JQ1联合诱导p-TEFb激活。
PLoS Pathog. 2015 Jul 30;11(7):e1005066. doi: 10.1371/journal.ppat.1005066. eCollection 2015 Jul.
9
An In-Depth Comparison of Latency-Reversing Agent Combinations in Various In Vitro and Ex Vivo HIV-1 Latency Models Identified Bryostatin-1+JQ1 and Ingenol-B+JQ1 to Potently Reactivate Viral Gene Expression.在各种体外和离体HIV-1潜伏模型中对潜伏期逆转剂组合进行的深入比较发现,苔藓抑素-1+JQ1和 ingenol-B+JQ1能有效重新激活病毒基因表达。
PLoS Pathog. 2015 Jul 30;11(7):e1005063. doi: 10.1371/journal.ppat.1005063. eCollection 2015 Jul.
10
Ex vivo analysis identifies effective HIV-1 latency-reversing drug combinations.体外分析确定了有效的HIV-1潜伏逆转药物组合。
J Clin Invest. 2015 May;125(5):1901-12. doi: 10.1172/JCI80142. Epub 2015 Mar 30.